Indeed, strange days are upon us: there's been a couple of explosions in the biotech space over the last week or so: ADO was a minnow who earned a solid revenue stream from a clinical tool - boomed 15 fold in a couple of days before settling to a mere 10 fold, and today VLA tripled on very promising results in a Phase-I melanoma trial.
Believe it or not folks but we are standing in the middle of a gold-rush frenzy that our forebears in Bathurst, Ballarat and Kalgoorlie would be familiar with.
Tana was sceptical that good Phase-III results would boost the Avexa SP. The reasoning is sound but somehow I think the game has changed.
Goes both ways of course - if Phase-III were to disappoint, then Avexa would become a legend in the space of a lunchtime for the rapidity of its fall.
One thing I think we can count on is that Avexa will call a trading halt before releasing anything dramatic - that didn't happen with either ADO or VLA !! Just 'price sentisitive announcements' !!
And people say Avexa's board is a bit sloppy!
Regards,
P.
- Forums
- ASX - By Stock
- AVX
- 3,000,000 buy order at 16
3,000,000 buy order at 16, page-17
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online